Shanghai Biomaterials Research & Testing Center, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Arch Toxicol. 2010 Mar;84(3):183-90. doi: 10.1007/s00204-009-0488-x.
As the biosafety of nanotechnology becomes a growing concern, the in vivo nanotoxicity of NPs has drawn a lot of attention. Silica nanoparticles (SiNPs) have been widely developed for biomedical use, but their biodistribution and toxicology have not been investigated extensively in vivo. Although investigations of in vivo qualitative distribution of SiNPs have been reported, the time-dependent and quantitative informations about the distribution of SiNPs are still lacking. Here we investigated the long-term (30 days) quantitative tissue distribution, and subcellular distribution, as well as potential toxicity of two sizes of intravenously administered SiNPs in mice using radiolabeling, radioactive counting, transmission electron microscopy and histological analysis. The results indicated that SiNPs accumulate mainly in lungs, liver and spleen and are retained for over 30 days in the tissues because of the endocytosis by macrophages, and could potentially cause liver injury when intravenously injected.
随着纳米技术的生物安全性日益受到关注,纳米颗粒的体内纳米毒性引起了广泛关注。硅纳米颗粒(SiNPs)已被广泛开发用于生物医学用途,但它们在体内的分布和毒理学尚未得到广泛研究。尽管已经报道了 SiNPs 体内定性分布的研究,但关于 SiNPs 分布的时间依赖性和定量信息仍然缺乏。在这里,我们使用放射性标记、放射性计数、透射电子显微镜和组织学分析研究了两种大小的静脉注射 SiNPs 在小鼠体内的长期(30 天)定量组织分布、亚细胞分布以及潜在毒性。结果表明,SiNPs 主要积聚在肺部、肝脏和脾脏中,并由于巨噬细胞的内吞作用而在组织中保留超过 30 天,并且当静脉注射时可能会导致肝脏损伤。